HustedS. Antithrombotic therapy for long-term secondary prevention of acute coronary syndrome in high-risk patients. Ther Clin Risk Manag. 2015;11:263–77.
2.
DoktorovaMMotovskaZ. Clinical review: bleeding—a notable complication of treatment in patients with acute coronary syndromes: incidence, predictors, classification, impact on prognosis, and management. Crit Care. 2013;17(5):239.
3.
NumasawaYKohsakaSUedaI. Incidence and predictors of bleeding complications after percutaneous coronary intervention. J Cardiol. 2017;69(1):272–9.
4.
LeeJHAhnSGParkB. A pharmacodynamic study of the optimal P2Y12 inhibitor regimen for East Asian patients with acute coronary syndrome. Korean J Intern Med. 2015;30(5):620–8.
5.
KangHJClareRMGaoR. Ticagrelor versus clopidogrel in Asian patients with acute coronary syndrome: a retrospective analysis from the Platelet Inhibition and Patient Outcomes (PLATO) trial. Am Heart J. 2015;169(6):899–905e1.
6.
MehtaRHParsonsLPetersonED; National Registry of Myocardial Infarction Investigators. Comparison of bleeding and in-hospital mortality in Asian-Americans versus Caucasian-Americans with ST-elevation myocardial infarction receiving reperfusion therapy. Am J Cardiol. 2012;109(7):925–31.
7.
WangTYChenAYRoeMT. Comparison of baseline characteristics, treatment patterns, and in-hospital outcomes of Asian versus non-Asian white Americans with non-ST-segment elevation acute coronary syndromes from the CRUSADE quality improvement initiative. Am J Cardiol. 2007;100(3):391–6.
MoscucciMFoxKACannonCP. Predictors of major bleeding in acute coronary syndromes: the Global Registry of Acute Coronary Events (GRACE). Eur Heart J. 2003;24(20):1815–23.
10.
ManoukianSVFeitFMehranR. Impact of major bleeding on 30-day mortality and clinical outcomes in patients with acute coronary syndromes: an analysis from the ACUITY trial. J Am Coll Cardiol. 2007;49(12):1362–8.
11.
MisumidaNOgunbayoGKimSM. Higher risk of bleeding in Asians presenting with ST-elevation myocardial infarction: analysis of the national inpatient sample database. Angiology. 2018;69(6):548–554.
12.
RossAMGaoRCoyneKS; TUCC Investigators. A randomized trial confirming the efficacy of reduced dose recombinant tissue plasminogen activator in a Chinese myocardial infarction population and demonstrating superiority to usual dose urokinase: the TUCC trial. Am Heart J. 2001;142(2):244–7.
13.
Second Chinese Cardiac Study Collaborative Group. Rationale, design and organization of the Second Chinese Cardiac Study (CCS-2): a randomized trial of clopidogrel plus aspirin, and of metoprolol, among patients with suspected acute myocardial infarction. Second Chinese Cardiac Study (CCS-2) Collaborative Group. J Cardiovasc Risk. 2000;7(6):435–41.
14.
DangMTHambletonJKayserSR. The influence of ethnicity on warfarin dosage requirement. Ann Pharmacother. 2005;39(2):1008–12.
15.
JeongYH. “East asian paradox”: challenge for the current antiplatelet strategy of “one-guideline-fits-all races” in acute coronary syndrome. Curr Cardiol Rep. 2014;16(5):485.
16.
LiuJJiangHHWuDK. Effect of gene polymorphims on the warfarin treatment at initial stage. Pharmacogenomics J. 2017;17(1):47–52.
17.
WakamiyaTHokosakiTTsujimotoS. Effect of VKORC1, CYP2C9, CFP4F2, and GGCX gene polymorphisms on warfarin dose in Japanese pediatric patients. Mol Diagn Ther. 2016;20(4):393–400.
18.
HuXTaoCXieZ. The MTHFR C677T polymorphism and risk of intracerebral hemorrhage in a Chinese Han population. Med Sci Monit. 2016;22:127–33.
19.
LeeYSJinCDKimMH. Comparison of prasugrel and ticagrelor antiplatelet effects in Korean patients presenting with ST-segment elevation myocardial infarction. Circ J. 2015;79(6):1248–54.
20.
SongYZhangBHuPJMaJ. Prevalence of anemia and its association with nutritional status among Chinese students of ethnic minorities in 2010 [in Chinese]. Beijing Da Xue Xue Bao. 2016;48(3):429–35.
21.
BarbourSJSchachterMErLDjurdjevOLevinA. A systematic review of ethnic differences in the rate of renal progression in CKD patients. Nephrol Dial Transplant. 2010;25(8):2422–30.
22.
ChewSTMarWMTiLK. Association of ethnicity and acute kidney injury after cardiac surgery in a South East Asian population. Br J Anaesth. 2013;110(3):397–401.
23.
MehranRPocockSJNikolskyE. A risk score to predict bleeding in patients with acute coronary syndromes. J Am Coll Cardiol. 2010;55(23):2556–66.
24.
AlexanderKPChenAYRoeMT. Excess dosing of antiplatelet and antithrombin agents in the treatment of non-ST-segment elevation acute coronary syndromes. JAMA. 2005;294(24):3108–16.
25.
LiHWangCLiuCLiRZouMChengG. Efficacy of short-term statin treatment for the prevention of contrast-induced acute kidney injury in patients undergoing coronary angiography/percutaneous coronary intervention: a meta-analysis of 21 randomized controlled trials. Am J Cardiovasc Drugs. 2016;16(3):201–19.
